Cross Country Healthcare, Inc. (CCRN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 241.06M | 236.76M | 250.05M | 274.07M | 293.41M | 309.94M | 315.12M | 339.77M | 379.17M | 414.04M | 442.29M | 540.7M |
| Revenue Growth % | -17.84% | -23.61% | -20.65% | -19.34% | -22.62% | -25.14% | -28.75% | -37.16% | -39.11% | -34.09% | -30.47% | -28.25% |
| Cost of Goods Sold | 197.13M | 188.78M | 199.13M | 218.07M | 234.75M | 247.95M | 250.96M | 268.97M | 301.88M | 323.55M | 344.93M | 417.56M |
| COGS % of Revenue | 81.78% | 79.73% | 79.63% | 79.57% | 80.01% | 80% | 79.64% | 79.16% | 79.61% | 78.14% | 77.99% | 77.23% |
| Gross Profit | 43.92M | 47.98M | 50.93M | 56M | 58.66M | 61.99M | 64.16M | 70.81M | 77.3M | 90.49M | 97.36M | 123.14M |
| Gross Margin % | 18.22% | 20.27% | 20.37% | 20.43% | 19.99% | 20% | 20.36% | 20.84% | 20.39% | 21.86% | 22.01% | 22.77% |
| Gross Profit Growth % | -25.12% | -22.6% | -20.62% | -20.9% | -24.11% | -31.49% | -34.1% | -42.5% | -44.56% | -34.87% | -32.18% | -27.74% |
| Operating Expenses | 45.87M | 55.08M | 56.9M | 61.86M | 59.63M | 65.42M | 61.3M | 90.01M | 74.38M | 77.06M | 77.06M | 87.95M |
| OpEx % of Revenue | 19.03% | 23.27% | 22.76% | 22.57% | 20.32% | 21.11% | 19.45% | 26.49% | 19.62% | 18.61% | 17.42% | 16.27% |
| Selling, General & Admin | 45.81M | 51.25M | 0 | 50.05M | 52.49M | 55.34M | 54.3M | 0 | 0 | 71.67M | 69.63M | 0 |
| SG&A % of Revenue | 19% | 21.65% | - | 18.26% | 17.89% | 17.86% | 17.23% | - | - | 17.31% | 15.74% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 61K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -1.95M | -7.1M | -5.97M | -5.86M | -977K | -3.43M | 2.85M | -19.21M | 2.92M | 13.42M | 20.3M | 35.19M |
| Operating Margin % | -0.81% | -3% | -2.39% | -2.14% | -0.33% | -1.11% | 0.91% | -5.65% | 0.77% | 3.24% | 4.59% | 6.51% |
| Operating Income Growth % | -99.69% | -106.85% | -309.36% | 69.49% | -133.45% | -125.57% | -85.95% | -154.58% | -93.33% | -73.92% | -61.09% | -55.36% |
| EBITDA | 1.72M | -3.27M | -1.89M | -1.76M | 3.79M | 208K | 7.35M | -14.49M | 7.56M | 17.39M | 24.84M | 39.62M |
| EBITDA Margin % | 0.71% | -1.38% | -0.75% | -0.64% | 1.29% | 0.07% | 2.33% | -4.26% | 1.99% | 4.2% | 5.62% | 7.33% |
| EBITDA Growth % | -54.73% | -1671.15% | -125.64% | 87.87% | -49.82% | -98.8% | -70.41% | -136.56% | -84.47% | -67.8% | -55.15% | -51.87% |
| D&A (Non-Cash Add-back) | 3.67M | 3.83M | 4.09M | 4.1M | 4.77M | 3.64M | 4.5M | 4.72M | 4.64M | 3.97M | 4.54M | 4.43M |
| EBIT | -1.95M | -70.68M | -5.08M | -5.18M | -356K | 341K | 3.94M | -13.03M | 8.11M | 14.32M | 20.17M | 36.63M |
| Net Interest Income | 407K | 314K | 308K | 153K | 138K | -73K | 557K | -568K | -462K | -586K | -664K | -3.15M |
| Interest Income | 974K | 882K | 864K | 702K | 681K | 535K | 1.11M | 0 | 0 | 0 | 5K | 0 |
| Interest Expense | 567K | 568K | 556K | 549K | 543K | 608K | 550K | 568K | 462K | 586K | 669K | 3.15M |
| Other Income/Expense | -1.78M | -64.14M | 336K | 130K | 78K | -481K | 536K | -356K | 768K | -455K | -803K | -4.88M |
| Pretax Income | -3.73M | -71.25M | -5.64M | -5.73M | -899K | -3.91M | 3.39M | -19.56M | 3.69M | 12.97M | 19.5M | 30.31M |
| Pretax Margin % | -1.55% | -30.09% | -2.25% | -2.09% | -0.31% | -1.26% | 1.08% | -5.76% | 0.97% | 3.13% | 4.41% | 5.61% |
| Income Tax | 532K | 11.68M | -863K | 930K | -409K | -161K | 834K | -3.51M | 997K | 3.93M | 6.69M | 8.96M |
| Effective Tax Rate % | -14.25% | -16.4% | 15.31% | -16.23% | 45.49% | 4.11% | 24.61% | 17.95% | 27.03% | 30.31% | 34.3% | 29.57% |
| Net Income | -4.27M | -82.93M | -4.77M | -6.66M | -490K | -3.75M | 2.56M | -16.05M | 2.69M | 9.04M | 12.81M | 21.34M |
| Net Margin % | -1.77% | -35.03% | -1.91% | -2.43% | -0.17% | -1.21% | 0.81% | -4.72% | 0.71% | 2.18% | 2.9% | 3.95% |
| Net Income Growth % | -770.61% | -2109.67% | -286.85% | 58.51% | -118.2% | -141.52% | -80.06% | -175.19% | -90.85% | -76.7% | -63.18% | -59.65% |
| Net Income (Continuing) | -4.27M | -82.93M | -4.77M | -6.66M | -490K | -3.75M | 2.56M | -16.05M | 2.69M | 9.04M | 12.81M | 21.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.14 | -2.56 | -0.15 | -0.20 | -0.02 | -0.12 | 0.08 | -0.47 | 0.08 | 0.26 | 0.36 | 0.60 |
| EPS Growth % | -600% | -2033.33% | -294.05% | 57.45% | -125.71% | -146.15% | -78.53% | -178.33% | -90.4% | -75.24% | -61.29% | -57.14% |
| EPS (Basic) | -0.14 | -2.56 | -0.15 | -0.20 | -0.02 | -0.12 | 0.08 | -0.47 | 0.08 | 0.26 | 0.37 | 0.60 |
| Diluted Shares Outstanding | 31.47M | 32.33M | 32.52M | 32.49M | 32.28M | 32.34M | 33.06M | 33.96M | 34.6M | 34.69M | 35.15M | 35.52M |
| Basic Shares Outstanding | 31.47M | 32.33M | 32.52M | 32.49M | 32.28M | 32.34M | 33.02M | 33.96M | 34.22M | 34.48M | 34.95M | 35.35M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |